Clinical Trial Update: A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies [Phase 2]

View source ↗

Summary

Phase 2 clinical study of anetumab ravtansine in adults with solid tumors; the trial has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Anetumab Ravtansine (anetumab ravtansine)

Snippet

Sponsor: Bayer | Conditions: Solid Tumors | Phase 2 | Status: TERMINATED | Results posted: 2023-08-04